The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Cannabis, a complex plant: different compounds and different effects on individuals
Open accessAbstract
Cannabis is a complex plant, with major compounds such as delta-9-tetrahydrocannabinol and cannabidiol, which have opposing effects. The discovery of its compounds has led to the further discovery of an important neurotransmitter system called the endocannabinoid system. This system is widely distributed in the brain and in the body, and is considered to be responsible for numerous significant functions. There has been a recent and consistent worldwide increase in cannabis potency, with increasing associated health concerns. A number of epidemiological research projects have shown links between dose-related cannabis use and an increased risk of development of an enduring psychotic illness. However, it is also known that not everyone who uses cannabis is affected adversely in the same way. What makes someone more susceptible to its negative effects is not yet known, however there are some emerging vulnerability factors, ranging from certain genes to personality characteristics. In this article we first provide an overview of the biochemical basis of cannabis research by examining the different effects of the two main compounds of the plant and the endocannabinoid system, and then go on to review available information on the possible factors explaining variation of its effects upon different individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“Mechoulam and colleagues isolated the second endocannabinoid neurotransmitter, 2-arachidonylglycerol (2-AG), 3 years later [Mechoulam et al. 1995].”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“Another cornerstone in cannabinoid research was the identification of the specific binding sites of d-9-THC in the brain [Devane et al. 1988], which was followed by the cloning of cannabinoid 1 receptor (CB1R) [Matsuda et al. 1990].”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Self-citationRusso, E., & Guy, G. W. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 610
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567 · cited 1×
“In a recent study of people with a first episode of psychosis, it was found that patients used higher-potency cannabis for longer durations and greater frequency compared with a healthy control group [Di Forti et al. 2009].”
ResultThe pharmacology of cannabinoid receptors and their ligands: an overview
Pertwee, R. G. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803272 · Cited by 557
Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535
Self-citationCannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Self-citationMechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486
Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Self-citationEmerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Molina-Holgado, E., Vela, J. M., Arévalo-Martı́n, A., Almazán, G., Molina-Holgado, F., Borrell, J., & Guaza, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09742.2002 · Cited by 419
Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395
Being stoned: a review of self‐reported cannabis effects
GREEN, B., KAVANAGH, D., & YOUNG, R. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390
An archaeological and historical account of cannabis in China
Li, H.-L. (1973) · Economic Botany · doi:10.1007/bf02862859 · Cited by 386
Curran, V., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 369
The Inheritance of Chemical Phenotype in Cannabis sativa L.
de Meijer, E. P. M., Bagatta, M., Carboni, A., Crucitti, P., Moliterni, V. M. C., Ranalli, P., & Mandolino, G. (2003) · Genetics · doi:10.1093/genetics/163.1.335 · Cited by 354
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
Pertwee, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980050 · Cited by 335
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Bátkai, S., Pacher, P., Osei-Hyiaman, D., Radaeva, S., Liu, J., Harvey-White, J., Offertáler, L., Mackie, K., Rudd, M. A., Bukoski, R. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143230.23252.d2 · Cited by 322
Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077503 · Cited by 305
Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man
Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90129-0 · Cited by 305
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández-Tiedra, S., Salazar, M., García-Taboada, E., Barcia, J., Guzmán, M., & Velasco, G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0688 · Cited by 301
Morrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., Kapur, S., & Murray, R. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005522 · Cited by 298
Cannabis and psychosis/schizophrenia: human studies
D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0024-2 · Cited by 295
Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis
Smieskova, R., Fusar-Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R. D., Drewe, J., Radue, E. W., McGuire, P. K., Riecher-Rössler, A., & Borgwardt, S. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.016 · Cited by 294
Nicholson, A. N., Turner, C., Stone, B. M., & Robson, P. J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125688.05091.8f · Cited by 291
A historical overview of chemical research on cannabinoids
Mechoulam, R., & Hanuš, L. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00184-5 · Cited by 282
Cannabinoid receptors and endocannabinoids: Evidence for new players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275
Regulation of nausea and vomiting by cannabinoids
Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 268
Antipsychotic effect of cannabidiol.
Zuardi, A. W., Morais, S. L., Guimarães, F. S., & Mechoulam, R. (1995) · PubMed · Cited by 264
Alkylamides from Echinacea Are a New Class of Cannabinomimetics
Raduner, S., Majewska, A., Chen, J.-Z., Xie, X.-Q., Hamon, J., Faller, B., Altmann, K.-H., & Gertsch, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601074200 · Cited by 258
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., Nosarti, C., O’Carroll, C., Allen, P., Seal, M. L., Fletcher, P. C., Crippa, J. A., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.17 · Cited by 246
Self-citationCannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Callén, L., Moreno, E., Barroso-Chinea, P., Moreno-Delgado, D., Cortés, A., Mallol, J., Casadó, V., Lanciego, J. L., Franco, R., Lluis, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335273 · Cited by 238
Potter, D. J., Clark, P., & Brown, M. B. (2008) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00603.x · Cited by 230
Russo, E. B., Guy, G. W., & Robson, P. J. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790150 · Cited by 228
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
Wallace, M. J., Wiley, J. L., Martin, B. R., & DeLorenzo, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01243-2 · Cited by 226
A community survey of adverse effects of cannabis use
Thomas, H. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01277-x · Cited by 215
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
Moreira, F. A., & Guimarães, F. S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.040 · Cited by 206
Iwamura, H., Suzuki, H., Ueda, Y., Kaya, T., & Inaba, T. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38760-9 · Cited by 200
Cascini, F., Aiello, C., & Tanna, G. D. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010032 · Cited by 200
Morgan, C. J. A., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T. P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001322 · Cited by 195
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Fraccaro, V., Atakan, Z., Martin-Santos, R., O'Carroll, C., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.011 · Cited by 195
Self-citationCannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
van Winkel, R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.152 · Cited by 183
Zammit, S., Spurlock, G., Williams, H., Norton, N., Williams, N., O'Donovan, M. C., & Owen, M. J. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036129 · Cited by 174
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule‐1
Ramer, R., Bublitz, K., Freimuth, N., Merkord, J., Rohde, H., Haustein, M., Borchert, P., Schmuhl, E., Linnebacher, M., & Hinz, B. (2012) · The FASEB Journal · doi:10.1096/fj.11-198184 · Cited by 169
Cannabis-Induced Psychosis-Like Experiences Are Associated with High Schizotypy
Barkus, E. J., Stirling, J., Hopkins, R. S., & Lewis, S. (2006) · Psychopathology · doi:10.1159/000092678 · Cited by 167
Prevalence and correlates of cannabis use in developed and developing countries
Hall, W., & Degenhardt, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32812144cc · Cited by 166
Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis
McGuire, P. K., Jones, P., Harvey, I., Williams, M., McGuffin, P., & Murray, R. M. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00053-b · Cited by 165
Dewey, W. L. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06864-4 · Cited by 165
Marcellino, D., Carriba, P., Filip, M., Borgkvist, A., Frankowska, M., Bellido, I., Tanganelli, S., Müller, C. E., Fisone, G., Lluis, C., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.011 · Cited by 164
Athanasiou, A., Clarke, A. B., Turner, A. E., Mohana‐Kumaran, N., Vakilpour, S., Smith, P. A., Bagiokou, D., Bradshaw, T. D., Westwell, A. D., Fang, L., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.107 · Cited by 157
Cannabinoid Receptors and Endocannabinoids: Evidence for New Players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149
Winton-Brown, T. T., Allen, P., Bhattacharrya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Martin-Santos, R., Ffytche, D., Zuardi, A. W., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.17 · Cited by 146
Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia
Degenhardt, L. J., Coffey, C., Carlin, J. B., Swift, W., Moore, E. E., & Patton, G. C. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056952 · Cited by 146
Hayakawa, K., Mishima, K., Hazekawa, M., Sano, K., Irie, K., Orito, K., Egawa, T., Kitamura, Y., Uchida, N., Nishimura, R., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.090 · Cited by 145
Navarro, G., Carriba, P., Gandía, J., Ciruela, F., Casadó, V., Cortés, A., Mallol, J., Canela, E. I., Lluís, C., & Franco, R. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.136 · Cited by 144
Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens
Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 138
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Marzo, V. D., Piscitelli, F., & Mechoulam, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_4 · Cited by 132
Hawkins, K. A., Mohamed, S., & Woods, S. W. (1999) · Psychological Medicine · doi:10.1017/s0033291798006990 · Cited by 120
Lakhan, S. E., & Rowland, M. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-59 · Cited by 120
Bhattacharyya, S., Atakan, Z., Martín‐Santos, R., Crippa, J. A., Kambeitz, J. P., Prata, D. P., Williams, S., Brammer, M. J., Collier, D. A., & McGuire, P. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.187 · Cited by 115
Self-citationTerry, G. E., Liow, J., Zoghbi, S. S., Hirvonen, J., Farris, A. G., Lerner, A., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.059 · Cited by 111
Waes, V. V., Beverley, J. A., Siman, H., Tseng, K. Y., & Steiner, H. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00021 · Cited by 107
Looking for the role of cannabinoid receptor heteromers in striatal function
Ferré, S., Goldberg, S. R., Lluís, C., & Franco, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.076 · Cited by 98
EFFECTS OF MARIHUANA IN LABORATORY ANIMALS AND IN MAN
Carlini, E. A., Karniol, I., Renault, P., & Schuster, C. R. (1974) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1974.tb08576.x · Cited by 91
Wood, T. B., Spivey, W. T. N., & Easterfield, T. H. (1899) · Journal of the Chemical Society Transactions · doi:10.1039/ct8997500020 · Cited by 90
Endocannabinoids and pregnancy.
Taylor, A. H., Amoako, A. A., Bambang, K., Karasu, T., Gebeh, A., Lam, P. M. W., Marzcylo, T. H., & Konje, J. C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.012 · Cited by 89
Kenney, S. P., Kekuda, R., Prasad, P. D., et al. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70583-1 · Cited by 88
Marijuana Smoking vs Cannabinoids for Glaucoma Therapy
Green, K. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.11.1433 · Cited by 86
Independent Versus Substance-Induced Major Depressive Disorder in Substance-Dependent Patients
Nunes, E. V., Liu, X., Samet, S., Matseoane, K., & Hasin, D. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1010 · Cited by 83
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone, J. M. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311400779 · Cited by 79
Psychopharmacology of the endocannabinoids: far beyond anandamide
Pamplona, F. A., & Takahashi, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405357 · Cited by 72
Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies for Psychiatric Conditions
Ross, E. M. (2001) · Nutrition in Clinical Care · doi:10.1046/j.1523-5408.2001.00147.x · Cited by 71
Cannabis-Induced Psychotic-Like Experiences Are Predicted by High Schizotypy
Stirling, J., Barkus, E., Nabosi, L., Irshad, S., Roemer, G., Schreudergoidheijt, B., & Lewis, S. W. (2008) · Psychopathology · doi:10.1159/000155215 · Cited by 69
Cardiovascular and Metabolic Considerations in Prolonged Cannabinoid Administration in Man
Benowitz, N. L., & Jones, R. T. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02598.x · Cited by 69
Sex, Drugs, and Cognition: Effects of Marijuana
Anderson, B. M., Rizzo, M., Block, R. I., Pearlson, G. D., & OʼLeary, D. S. (2010) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2010.10400704 · Cited by 69
Anglin, D. M., Corcoran, C. M., Brown, A. S., Chen, H., Lighty, Q., Brook, J. S., & Cohen, P. R. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.019 · Cited by 67
Bhattacharyya, S., Crippa, J. A., Martín‐Santos, R., Winton‐Brown, T., & Fusar‐Poli, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788957465 · Cited by 52
Cannabinoids and intestinal motility: welcome to CB2 receptors
Izzo, A. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705890 · Cited by 43
Are early-onset cannabis smokers at an increased risk of depression spells?
Fairman, B. J., & Anthony, J. C. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.031 · Cited by 43
Comparative Studies in Man and in Laboratory Animals on ▵ 8 - and ▵ 9 -trans-Tetrahydrocannabinol
Karniol, I. G., & Carlini, E. A. (2008) · Pharmacology · doi:10.1159/000136375 · Cited by 43
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 37
Subjective Effects of Cannabis Before the First Psychotic Episode
Peters, B. D., de Koning, P. P., Dingemans, P. M. A. J., Becker, H. E., LINSZEN, D. H., & de Haan, L. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903179095 · Cited by 36
Dakwar, E., Nunes, E. V., Bisaga, A. M., Carpenter, K. C., Mariani, J. P., Sullivan, M. A., Raby, W. N., & LEVIN, F. R. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00148.x · Cited by 35
Gut feelings about the endocannabinoid system
Marzo, V. D., & Piscitelli, F. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01689.x · Cited by 29
Methods for Clinical Research Involving Cannabis Administration
Gorelick, D. A., & Heishman, S. J. (2006) · Humana Press eBooks · doi:10.1385/1-59259-999-0:235 · Cited by 22
Cannabidiol as an anxiolytic and antipsychotic
Zuardi, A. W., & Guimarães, F. S. (1998) · Cited by 20
Cited by
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Hall, W. (2015) · Addiction · doi:10.1111/add.12703 · Cited by 579
GABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al-Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 405
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
Levine, A., Clemenza, K., Rynn, M., & Lieberman, J. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.12.014 · Cited by 239
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
Metadata
- Authors
- Atakan, Z.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-09-05
- Volume
- 2
- Issue
- 6
- Pages
- 241-254
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- OpenAlex
- W2146565954
- Cited by
- 544
- References
- 107
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.